These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12838515)

  • 1. A turn of the sulfatide in Alzheimer's disease.
    Irizarry MC
    Ann Neurol; 2003 Jul; 54(1):7-8. PubMed ID: 12838515
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current aspects of Alzheimer's disease].
    van Gool WA; Eikelenboom P
    Ned Tijdschr Geneeskd; 1994 Jan; 138(3):116-8. PubMed ID: 8295635
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.
    Cheng H; Xu J; McKeel DW; Han X
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):809-18. PubMed ID: 14528918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia.
    Han X; Fagan AM; Cheng H; Morris JC; Xiong C; Holtzman DM
    Ann Neurol; 2003 Jul; 54(1):115-9. PubMed ID: 12838527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease. Risky apolipoprotein in brain.
    Goedert M; Strittmatter WJ; Roses AD
    Nature; 1994 Nov; 372(6501):45-6. PubMed ID: 7969418
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta amyloid's accomplice? Molecular hit man might help Alzheimer's protein take out brain's white matter.
    Leslie M
    Sci Aging Knowledge Environ; 2004 Jan; 2004(2):nf8. PubMed ID: 14724324
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cholesterol metabolic disorders and Alzheimer's disease].
    Hao JW; Li L
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):64-6. PubMed ID: 15881350
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular epidemiology of Alzheimer's disease.
    Hyman BT; Tanzi R
    N Engl J Med; 1995 Nov; 333(19):1283-4. PubMed ID: 7566008
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's disease: genetic variables and risk.
    Secko D
    CMAJ; 2005 Mar; 172(5):627. PubMed ID: 15738483
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apolipoprotein E and its receptors in Alzheimer's disease].
    Ikeda K
    Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1465-9. PubMed ID: 8741398
    [No Abstract]   [Full Text] [Related]  

  • 12. Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease.
    Sobów T; Flirski M; Liberski PP
    Acta Neurobiol Exp (Wars); 2004; 64(1):53-70. PubMed ID: 15190680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer research forum live discussion: Making a BioMark on Alzheimer disease.
    J Alzheimers Dis; 2005 Mar; 8(4):393-9. PubMed ID: 16646143
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What causes Abeta amyloidosis in the brain?].
    Matsubara E; Yanagisawa K
    No To Shinkei; 2005 Oct; 57(10):829-38. PubMed ID: 16277228
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer's disease].
    Giménez-Roldán S
    Rev Clin Esp; 1995 Jul; 195(7):445-7. PubMed ID: 7667517
    [No Abstract]   [Full Text] [Related]  

  • 18. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME; Gouras G; Relkin NR; Szabo P
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
    Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
    Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
    Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.